Last updated on March 2018

Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer (ARAMIS)

Brief description of study

The purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.

Clinical Study Identifier: NCT02200614

Contact Investigators or Research Sites near you

Start Over

Praha 2, Czechia

Praha 8, Czechia

Praha 6, Czechia